简约亚表型算法在脓毒症合并血液恶性肿瘤患者中表现不同
这项单中心前瞻性队列研究纳入930例以脓毒症为主要入ICU指征的成人患者,其中396例(42%)有活动性恶性肿瘤。研究者应用两种已发表的亚表型算法(分别利用IL-6或IL-8,外加可溶性肿瘤坏死因子受体1和碳酸氢盐)进行分型。在血液恶性肿瘤患者中,IL-8算法判定的高炎症亚表型比例高于IL-6算法(58% vs 32%)。Cox比例风险模型显示,血液恶性肿瘤削弱了IL-6算法高炎症亚表型与死亡率的关联(交互作用p=0.037),但未削弱IL-8算法高炎症亚表型的死亡关联(交互作用p=0.260),后者在血液恶性肿瘤患者中仍保留独立死亡关联(HR 1.50,95%CI 1.08-2.07,p=0.014)。作者认为这些算法在血液恶性肿瘤患者中的差异表现提示需要在该特定人群中独立推导和验证。
要点
- 在930例脓毒症ICU患者中,396例(42%)有活动性恶性肿瘤;血液恶性肿瘤患者中IL-8算法判定的高炎症亚表型比例为58%,IL-6算法为32%。
- 血液恶性肿瘤削弱了IL-6算法高炎症亚表型与死亡率的关联(交互作用p=0.037),但未削弱IL-8算法高炎症亚表型的死亡关联(交互作用p=0.260)。
- 在血液恶性肿瘤患者中,IL-8算法判定的高炎症亚表型仍与死亡率独立相关(HR 1.50,95%CI 1.08-2.07,p=0.014)。
- 白血病合并中性粒细胞减少的患者在IL-8算法判定的高炎症亚表型中占比过高。
- 作者认为这些算法在血液恶性肿瘤患者中的差异表现提示需要在该特定人群中独立推导和验证。
适用人群与场景
- 年龄大于18岁、以脓毒症为主要入ICU指征的ICU患者,来自美国单家四级转诊中心的前瞻性队列(930例),其中396例(42%)有活动性恶性肿瘤。
研究设计与关键结果
- 研究类型为单中心前瞻性队列研究,样本量930例,人群为以脓毒症为主要入ICU指征的成人ICU患者,396例(42%)有活动性恶性肿瘤;无干预。
- 应用两种已发表亚表型算法(分别利用IL-6或IL-8,外加可溶性肿瘤坏死因子受体1和碳酸氢盐)进行分型。
- 血液恶性肿瘤患者中,IL-8算法判定的高炎症亚表型比例为58%,IL-6算法为32%。
- 白血病合并中性粒细胞减少的患者在IL-8算法判定的高炎症亚表型中占比过高。
- Cox比例风险模型显示,血液恶性肿瘤削弱了IL-6算法高炎症亚表型与死亡率的关联(交互作用p=0.037),但未削弱IL-8算法高炎症亚表型的死亡关联(交互作用p=0.260)。
- 在血液恶性肿瘤患者中,IL-8算法判定的高炎症亚表型仍保留独立死亡关联(HR 1.50,95%CI 1.08-2.07,p=0.014)。
证据类型、等级与局限
- 证据类型:单中心前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,随着亚表型算法被作为床旁预后工具进行测试,了解其在合并恶性肿瘤患者中的可推广性很重要,因为恶性肿瘤患者在ICU患者中所占比例日益增加。
- 作者认为,这些算法在血液恶性肿瘤患者中的差异表现提示需要在该特定人群中独立推导和验证。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Latent class assignment-derived subphenotyping algorithms may identify treatment-responsive subgroups of critically ill patients with sepsis and acute respiratory distress syndrome. It is unclear if these algorithms are generalizable to patients with comorbid malignancy, a state which may perturb influential inflammatory biomarkers. This study aimed to test whether malignancy or neutropenia modified the effect of subphenotype assignment by two algorithms as applied to a prospective cohort enriched for ICU patients with active malignancy.
DESIGN: Prospective cohort study at a single U.S. quaternary referral center.
SETTING/PATIENTS: ICU patients older than 18 admitted to an ICU with a primary admission indication of sepsis.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We applied two published subphenotyping algorithms utilizing either interleukin (IL)-6 or IL-8 (in addition to soluble tumor necrosis factor receptor 1 and bicarbonate) to our cohort of 930 patients with sepsis, 396 (42%) of whom had active malignancy. A greater proportion of hematologic malignancy patients were assigned the "hyperinflammatory" subphenotype by the IL-8-utilizing algorithm than the IL-6 algorithm (58% vs. 32%). Patients with leukemia and neutropenia were overrepresented among those classified as hyperinflammatory by IL-8 algorithm. We constructed Cox proportional hazards models to assess for interaction between the presence of solid malignancy, hematologic malignancy, and severe neutropenia and the subphenotype/mortality association. Hematologic malignancy uniquely appeared to attenuate the associated mortality of the IL-6-assigned hyperinflammatory subphenotype (interaction; p = 0.037), but not the IL-8-assigned hyperinflammatory subphenotype (interaction; p = 0.260), which retained an independent association with mortality in hematologic malignancy subjects (hazard ratio, 1.50; 95% CI, 1.08-2.07; p = 0.014).
CONCLUSIONS: As subphenotyping algorithms are being tested as point-of-care prognostic tools, it is important to understand their generalizability to patients with comorbid malignancy, which constitute an increasing proportion of ICU patients. The differential behavior of these algorithms in patients with hematologic malignancy suggests a need for independent derivation and validation in this specific population.
参考来源
- Ronner L, Giannini HM, Miano TA, et al. Parsimonious Subphenotyping Algorithms Perform Differently in Patients With Sepsis and Hematologic Malignancy. Crit Care Med. 2025. PMID: 40637495. doi:10.1097/CCM.0000000000006774
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。